AstraZeneca PLC/ GB0009895292 /
| 2024-04-19 4:51:11 PM | Chg. +3.00 | Volume | Bid4:51:21 PM | Ask4:51:21 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 10,923.00GBX | +0.03% | 118,537 Turnover(GBP): 12.86 mill. |
10,916.00Bid Size: 16 | 10,920.00Ask Size: 53 | 168.76 bill.GBP | - | - |
Business description
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Management board & Supervisory board
| CEO |
|---|
| Pascal Soriot |
| Management board |
| Aradhana Sarin, Pam Cheng, Ruud Dobber, Marc Dunoyer, David Fredrickson, Susan Galbraith, Menelas (Mene) Pangalos, Jeff Pott, Iskra Reic, Leon Wang, Sharon Barr |
| Supervisory board |
| Michel Demaré, Pascal Soriot, Aradhana Sarin, Philip Broadley, Euan Ashley, Deborah DiSanzo, Diana Layfield, Sheri McCoy, Tony Mok, Nazneen Rahman, Andreas Rummelt, Marcus Wallenberg |
Company data
| Name: | AstraZeneca plc |
| Address: | 1 Francis Crick Avenue Cambridge Biomedical Campus,Cambridge, CB2 0AA United Kingdom |
| Phone: | 0800 783 0033 |
| Fax: | +44-20-7604-8151 |
| E-mail: | Medical.InformationU...eca.com Medical.InformationUK@astrazeneca.com |
| Internet: | www.astrazeneca.com |
| Industry: | Healthcare |
| Sector: | Pharmaceutical Industry |
| Sub sector: | Pharmaceuticals |
| End of financial year: | 12-31 |
| Free Float: | - |
| IPO date: | 1999-04-06 |
Investor relations
| Name: | Andy Barnett |
| IR phone: | +44 (0)20 3749 5000 |
| IR Fax: | - |
| IR e-mail: | CorporateAccess@astrazeneca |
Company calendar
| CW 17 | 2024-04-25 Interim Report 1st Quarter/3 Months |
| CW 30 | 2024-07-25 Interim Report 2nd Quarter/6 Months |
| CW 32 | 2024-08-08 Ex-Dividend |
| CW 32 | 2024-08-09 Record Date |
| CW 37 | 2024-09-09 Dividend Payment |
Main Shareholders
| Others | 77.64% | |
| BlackRock, Inc. | 6.51% | |
| Wellington Management Company LLP | 4.20% | |
| Wellington Management Group LLP | 4.20% | |
| The Capital Group Companies, Inc | 4.12% | |
| Investor AB | 3.33% |
